Fiftyfive5’s King named head of pharma
In the newly created role, King will lead and continue to grow the agency’s pharmaceutical team. He has over 20 years of consulting experience, much of which has been spent in the pharma sector in Australia and overseas.
Prior to joining the company in 2014, King was managing director at M&C Saatchi’s strategy consultancy Clear.
Mark Sundquist, managing partner, Fiftyfive5, said: “Pharma is a key growth driver for the business and Alan is the perfect person to capture and build on the momentum we already have in this space. We have a large team of skilled pharma practitioners and we are excited about the significant opportunity that exists.”

We hope you enjoyed this article.
Research Live is published by MRS.
The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.
Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.
For example, there's an archive of winning case studies from over a decade of MRS Awards.
Find out more about the benefits of joining MRS here.
0 Comments